Rebopag Tablets

Rebopag Tablets Specification

Life Span
Check expiry date on packaging

Packaging Type
Box

Dosage Form
Solid, Oral tablet

Brand Name
Rebopag

Salt Composition
Eltrombopag 50 mg

Indication
Chronic immune thrombocytopenia (ITP)

Pacakaging (Quantity Per Box)
7 tablets per box

Origin of Medicine
India

Drug Type
Prescription only

Ingredients
Eltrombopag

Physical Form
Tablet

Function
Thrombopoietin receptor agonist, increases platelet counts

Recommended For
Patients with chronic ITP (Idiopathic Thrombocytopenic Purpura)

Dosage
As directed by a physician

Dosage Guidelines
Take orally as directed by your health practitioner

Suitable For
Adults and children as prescribed

Quantity
7 tablets

Storage Instructions
Store below 30C, in a dry place

Administration Route
Oral

Prescription Requirement
Yes

Side Effects
Refer to patient information leaflet

Therapeutic Class
Hematopoietic agent

About Rebopag Tablets

Discover the enlightened choice for managing chronic ITP with Rebopag Tablets, a majestic solution containing 50 mg of Eltrombopag per oral tablet. Heroically formulated as a thrombopoietin receptor agonist, Rebopag increases platelet count, empowering you on your health journey. Administered under strict medical supervision, this prescription-only medicine is suitable for both adults and children as prescribed. Take advantage of advance purchase options, utilise our exclusive offer, and Shop Now for a reliable supply. Each box contains 7 solid oral tablets, delivering confidence with every dose. Store below 30C and refer to the packaging for the exact expiry date.

Rebopag Tablets: Guidance on Usage and Suitability

Rebopag Tablets are designed for oral administration, specifically recommended for patients diagnosed with chronic idiopathic thrombocytopenic purpura (ITP). Suitable for adults and children as directed by a physician, these tablets are used to elevate platelet counts. Dosage and frequency should be strictly followed as advised by your healthcare provider, ensuring therapeutic efficacy and safety throughout your treatment.

Sample Accessibility, Export Markets, and Supply Dynamics

Samples of Rebopag Tablets can be requested for eligible parties, allowing you to estimate benefits and suitable application. We facilitate dispatching to key export markets across Asia, Africa, and the Middle East, ensuring prompt supply to meet growing demand. Our robust supply chain ensures minimal expenditure on delays with a reliable ability to fulfill bulk orders efficiently, reinforcing our commitment to healthcare excellence.

FAQ's of Rebopag Tablets:

Q: How should Rebopag Tablets be taken for effective results?

A: Rebopag Tablets should be taken orally, exactly as directed by your physician, to ensure effective and safe results in managing chronic ITP. Do not alter the dosage without medical supervision.

Q: What is the primary benefit of using Rebopag Tablets?

A: The primary benefit of Rebopag Tablets is their ability to increase platelet counts in patients with chronic immune thrombocytopenia (ITP), thereby helping reduce the risk of excessive bleeding.

Q: When should Rebopag Tablets be used during treatment?

A: Rebopag Tablets are used as part of ongoing management for chronic ITP as advised by a healthcare provider, often when other treatments have been inadequate or unsuitable.

Q: Where can I find information on the shelf life or expiry of Rebopag Tablets?

A: You can refer to the packaging of Rebopag Tablets for specific expiry date information. Always check this before use to ensure product integrity.

Q: What is the process for storing Rebopag Tablets safely?

A: Store Rebopag Tablets below 30C in a dry place, away from moisture and direct sunlight, to maintain their effectiveness throughout their shelf life.

Q: How is Rebopag Tablets' dosage determined for patients?

A: Dosage of Rebopag Tablets is individualized and determined by your physician based on clinical assessment and specific patient needs, ensuring optimal therapeutic outcomes.